Related Articles
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma
Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study
Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma
Mps1 is associated with the BRAFV600E mutation and predicts poor outcome in patients with colorectal cancer
Clinical and molecular assessment of regorafenib monotherapy